On a recent episode of APDA’s Dr. Gilbert Hosts, Dr. Gilbert spoke with Dr. Malu Gamez Tansey, the James A. Caplin, MD Chair in Alzheimer’s Disease at Indiana University School of Medicine and Director of Neuroimmunology Research Group, with expertise in the relationship between gut inflammation and Parkinson’s disease (PD). We covered a lot of ground […]
In August 2025, the American Parkinson Disease Association (APDA) welcomed Anne Hubbard as its first-ever Chief Public Policy Officer, marking a major step forward in strengthening the organization’s voice in public policy and advocacy. Anne now leads APDA’s newly created Department of Public Policy & Advocacy, where she is developing a comprehensive strategy to promote […]
We’re at a Turning Point for Parkinson’s — Your Story Can Help Move Congress The Parkinson’s disease (PD) community is currently facing both urgent challenges and real opportunities. More than 90,000 Americans are diagnosed each year, and over 1 million people are living with Parkinson’s nationwide. At the same time, new legislation, scientific progress, and […]
Announcing Bridge Funding to Alleviate Parkinson’s Research Funding Cuts The American Parkinson Disease Association (APDA) funds cutting-edge research every year, identifying the most promising researchers and projects through a meticulous evaluation process. APDA has recently gone a step further to ensure that researchers who are facing unexpected delays and even cuts in funding have a […]
A closer look at our newest research center at Yale University The American Parkinson Disease Association (APDA) is proud to support nine Centers for Advanced Research which, along with a variety of funded grants and fellowships, are the backbone of our research program. At these Centers, some of the most compelling PD research is underway – research […]
Dr. Gilbert chats with Dr. Okeanis Vaou about how climate may affect PD Living with Parkinson’s disease (PD) often means learning to adapt to changes in movement, thinking, and overall health. What many people don’t realize is that the environment, particularly temperature, humidity, and altitude—can also have a significant effect on symptoms. Recently, APDA’s Chief […]
What is Young Onset Parkinson’s Disease? When Parkinson’s disease (PD) is diagnosed between the ages of 21 and 50, it is called young onset, or early onset Parkinson’s disease (YOPD). Though symptoms overlap with typical PD, younger people face unique challenges, and even some surprising advantages, in managing the disease. Who Gets Young Onset […]
Tips for Traveling with Parkinson’s Disease People travel for many reasons – to see family, for business purposes, to explore new sites or just to relax and unwind. Traveling often brings unexpected challenges, especially for those with Parkinson’s disease (PD). However, with proper and proactive planning, there is no need to let PD hold you […]
Supporting Innovative Scientists and Breakthrough Discoveries The American Parkinson Disease Association (APDA) proudly announces $4.04 million in new funding for cutting-edge Parkinson’s disease (PD) research – representing a 55% increase in research funding from the previous year. These new awards support a remarkable group of scientists, each dedicated to advancing our understanding of PD and […]
Parkinson’s disease (PD) is typically diagnosed based on clinical exam, but there are imaging tests that are available to help in diagnosis. The most commonly known in the US is the Dopamine Transporter Scan (DaTscan), an imaging test in which a radioactive tracer, Ioflupane (123I) — which is also called DaTscan — is injected into the […]
Simple Email Signup v2 (Salsa replacement form)
